Skip to content
Research Article Open access CC BY 4.0

Papanicoleau Smear Usage and Prevalence of Premalignant Cervical Lesion among Women Living with HIV Attending a Federal Teaching Hospital in South-West Nigeria: A Comparative Study

Aishatu Omoragbon, Olusegun Emmanuel Gabriel, Olabode Muftau Shabi, Oluwaserimi Adewumi Ajetunmobi, Olayide Toyin Elegbede, Segun Mathew Agboola, Adebara Idowu Oluwaseyi

Journal of Cancer and Tumor International · pp. 1–9 · Published 2 Jun 2017

10.9734/JCTI/2017/33231

Abstract

Aim: Cancer of the cervix is the third most common cancer among women worldwide, and in Nigeria it is the second most common female cancer. Infection with the Human immunodeficiency virus (HIV) is associated with an increased risk of prevalent, incident and persistent squamous intraepithelial lesions (SILs) of the cervix. The aim was to determine the level of awareness of cervical cancer screening test and the development of premalignant cervical lesions among HIV positive women. Study Design: A Hospital based comparative cross-sectional study. Place and Duration of the Study: The study was carried out in the HIV clinic and general outpatient clinic of Federal Teaching Hospital Ido-ekiti, Ekiti state Nigeria. It was carried out from July to September 2015. Methodology: The study was carried out among 65 HIV-positive and 65 HIV-negative women.  Data were collected from the interviewees. Participants also had Pap smear. Data collected were analyzed using statistical package for social sciences version 19.                                                                                                                                              Results: The mean age was 39.73 (±8.57) and 40.98 (±10.68) among the HIV positive and negative women respectively. Only 27.7% of the HIV-positive women compared to 56.9% of the HIV negative women had heard of cervical cancer with P= 0.001. The level of awareness of cervical cancer screening test was 15.4% and 50.8% among the HIV positive and negative women respectively (P= 0.001). The prevalence of premalignant cervical lesions among the study and control groups was 26.2% and 16.9% respectively. This showed that premalignant cervical lesion was more prevalent among HIV-positive women though not statistically significant (P=0.201). However, using risk ratio (RR), the risk of developing cervical lesions is 1.55 times more in HIV exposed women than HIV negative women.                                                                       Conclusion: There is therefore need for the Physicians to use every opportunity to counsel their clients on the need for routine cervical cancer screening especially in adult HIV clinics.  

HIV-positive women Papanicoleau smear premalignant cervical lesions prevalence

References (24)

  1. 1 Cancer incidence in Nigeria: A report from population-based cancer registries [DOI]
  2. 2 Spectrum of cancers among HIV‐infected persons in Africa: The Uganda AIDS‐Cancer Registry Match Study [DOI]
  3. 3 Awareness, perception and factors affecting utilization of cervical cancer screening services among women in Ibadan, Nigeria: a qualitative study [DOI]
  4. 4 Cervical Cancer and Pap Smear Awareness and Utilization of Pap Smear Test among Federal Civil Servants in North Central Nigeria [DOI]
  5. 5 Awareness and uptake of cervical cancer screening in Owerri, South-Eastern Nigeria [DOI]
  6. 6 Willingness and acceptability of cervical cancer screening among HIV positive Nigerian women [DOI]
  7. 7 Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. New York Cervical Disease Study.
  8. 8 Cervical Cancer Screening of Women Living with HIV Infection: A Must in the Era of Antiretroviral Therapy [DOI]
  9. 9 Knowledge, attitude and practice of cervical cancer screening (pap smear) among female nurses in Nnewi, South Eastern Nigeria.
  10. 10 Prevalence and Risk Factors Associated with Precancerous Cervical Cancer Lesions among HIV-Infected Women in Resource-Limited Settings [DOI]
  11. 11 The Prevalence of Precancerous Cervical Cancer Lesion among HIV-Infected Women in Southern Ethiopia: A Cross-Sectional Study [DOI]
  12. 12 Cervical cancer risk factors among HIV-infected Nigerian women [DOI]
  13. 13 Knowledge and attitude towards cervical cancer screening among female students and staff in a tertiary institution in the Niger Delta [DOI]
  14. 14 Cancer burden among HIV-positive persons in Nigeria: preliminary findings from the Nigerian AIDS-cancer match study [DOI]
  15. 15 Cervical Cancer: Community Perception and Preventive Practices in an Urban Neighborhood of Lagos (Nigeria) [DOI]
  16. 16 The Association between HIV Infection, Antiretroviral Therapy and Cervical Squamous Intraepithelial Lesions in South Western Nigerian Women [DOI]
  17. 17 Prevalence of abnormal cervical smears among patients with HIV in Lagos, Nigeria.
  18. 18 An appraisal of the level of awareness and utilization of the Pap smear as a cervical cancer screening test among female health workers in a tertiary health institution [DOI]
  19. 19 Prevalence of cervical squamous intraepithelial lesions among HIV-positive women in Enugu, South-eastern Nigeria [DOI]
  20. 20 HIV Seroprevalence in Patients with Carcinoma of the Cervix in Ibadan, Nigeria.
  21. 21 Abnormal cervical cytology among HIV-positive women in Nigeria [DOI]
  22. 22 Prevalence and risk factors for cervical intraepithelial neoplasia among HIV-infected women [DOI]
  23. 23 Low Prevalence of Cervical Cancer Screening Among HIV-Positive Women in Catalonia (Spain) [DOI]
  24. 24 Cervical Cytopathology Pattern Among HIV Seropositive And HIV Seronegative Women In Zaria

Cited by 1

Article metrics

Real usage data collected on this platform.

40

Page views

0

PDF downloads

4

Outbound clicks

1

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.